Apnimed (APMD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 12 37 sessions, July 31, 2026 to September 22, 2026
- Largest daily move
- -11.6% close of August 31, 2026
Company Description
Apnimed (NASDAQ: APMD) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $908.4M.
APMD has declined 9.0% over the past month. The last closing price was $25.51.
This page collects what Stock Titan holds for APMD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Apnimed (APMD) closed at $25.51 on September 22, 2026. Over the past month, the price has lost 9.0%.
APMD Metrics & Rankings
Price returns through September 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Apnimed has 4 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, IPO, offering. View all APMD news →
SEC Filings
Apnimed has filed 10 recent SEC filings, including 6 Form 4, 2 Form SCHEDULE 13G, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on September 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all APMD SEC filings →
Insider Radar
Insider buying activity at Apnimed over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
FDA decision date
Apnimed has 1 upcoming scheduled event. The next event, "FDA decision date", is scheduled for February 28, 2027 (in 157 days). Investors can track these dates to stay informed about potential catalysts that may affect the APMD stock price.
Short Interest History
Short interest in Apnimed (APMD) currently stands at 564.8 thousand shares, up 38.6% from the previous reporting period, representing 2.7% of the float. Since August 2026, short interest has increased by 38.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Apnimed (APMD) currently stands at 1.5 days, up 51% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 51% over the past year, indicating either rising short interest or declining trading volume.
APMD Company Profile & Sector Positioning
Apnimed (APMD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.